Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baby Exemestane vs Baby Tamoxifen in High Risk Breast Cancer
NCT06364267Phase 2Recruiting
- Start
- Oct 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exemestane in breast cancer. Started Oct 2025; status: recruiting.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06364267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06364267.